Celerion's Drug Development Services helps pharmaceutical and biotechnology companies demonstrate early evidence of their compounds' clinical efficacy and tolerance in humans.
The knowledge and leadership of highly trained scientists enable clients to design and carry out comprehensive development strategies. Celerion’s integrated service spans the research process for small and large molecule drugs from lead identification through clinical proof-of-concept – and all the way to full clinical development.
Celerion offers expertise in pharmacology, chemogenomics, drug metabolism, pharmacokinetics, analytical chemistry, toxicology and safety pharmacology, bioanalysis, clinical pharmacology, biomarker strategies, early clinical research, regulatory strategy and submissions support, including CMC sections of regulatory documents.